Hema Tallman: Honored To Be Appointed Chair of the Global Plasma Board of PPTA
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”I have dedicated much of my career to leading large healthcare organizations, where teams collaborate daily to serve patients, pharmacists, clinicians, and communities.
A key realization I’ve come to is that the most significant challenges in healthcare cannot be addressed by any single company; they require our industry to work together.
I am honored to have been appointed Chair of the Global Plasma Board of the Plasma Protein Therapeutics Association (PPTA).
The plasma-derived therapies community exemplifies what collaboration across the healthcare ecosystem can achieve.
From plasma donors to manufacturers, healthcare providers, scientists, regulators, and, most importantly, our patients, thousands contribute to therapies that people around the world rely on every day.
Leading organizations with over 11,000 employees has imparted many lessons about leadership at scale.
One crucial lesson is that trust is not established through words but through consistent, collective action.
As trust in healthcare systems faces global challenges, the need for transparent and collaborative efforts across the industry has never been more critical.
I am grateful for the opportunity to contribute to this important work alongside my fellow board members and the broader PPTA community.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children